Intrinsiqs

Is Medpace Holdings, Inc. overvalued?

Medpace Holdings, Inc. (MEDP) looks overvalued — trading about 10% above its fair value.

Overvalued
Current price $586.52 Fair value $529.78
Price
$586.52
Fair value
$529.78
Current P/E
36.9
Normal P/E
33.3
Market cap
$16.37B
Dividend yield
0.0%
Return on equity
110.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares MEDP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedRHHBY Roche Holding AGMRK Merck & Co., Inc.